Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SUGP2 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
mRNA | C17orf99 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
mRNA | ZNF766 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
mRNA | SUSD3 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
mRNA | USP4 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
mRNA | HOXA7 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
mRNA | ZNF577 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
mRNA | CTNNAL1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
mRNA | NRDC | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
mRNA | PIP5K1B | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |